Erysiphe cruciferarum

From WikiMD's Medical Encyclopedia

Revision as of 20:45, 16 March 2025 by Prab (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Erysiphe cruciferarum is a species of fungus in the family Erysiphaceae. It is a plant pathogen that primarily affects members of the Brassicaceae family, which includes many economically important crops such as cabbage, broccoli, and mustard plants.

Taxonomy[edit]

The species was first described in 1877 by the German mycologist Heinrich Anton de Bary. It belongs to the genus Erysiphe, which comprises over 100 species of powdery mildew fungi.

Description and Life Cycle[edit]

Like all powdery mildew fungi, E. cruciferarum is characterized by its white, powdery growth on the surface of infected plants. The fungus reproduces asexually through the production of conidia, which are spread by wind to new host plants. Sexual reproduction occurs through the formation of ascospores, which are released from sac-like structures called asci.

Hosts and Symptoms[edit]

E. cruciferarum primarily infects plants in the Brassicaceae family. Symptoms of infection include white, powdery patches on the leaves, stems, and sometimes flowers of the host plant. Severe infections can lead to yellowing and wilting of the leaves, reduced growth, and decreased yield.

Management[edit]

Management of E. cruciferarum involves a combination of cultural practices, such as crop rotation and sanitation, and the use of fungicides. Resistant varieties of Brassicaceae crops are also available.

See Also[edit]

References[edit]

This article is a stub related to fungus. You can help WikiMD by expanding it!


Erysiphe cruciferarum gallery[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.